Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Prediction of progression from refractory cytopenia with unilineage dysplasia by analysis of bone marrow blast cell composition.
Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Breccia M, Latagliata R, Cannella L, Carmosino I, Santopietro M, Loglisci G, Federico V, Alimena G.
Leuk Lymphoma. 2010 May;51(5):783-8. doi: 10.3109/10428191003682759.
Prediction of progression from refractory cytopenia with unilineage dysplasia by analysis of bone marrow blast cell composition.
Oka S, Muroi K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Hanafusa T.
J Clin Exp Hematop. 2012;52(1):63-6. doi: 10.3960/jslrt.52.63.
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
Gyan E, Andrieu V, Sanna A, Caille A, Schemenau J, Sudaka I, Siguret V, Malet M, Park S, Bordessoule D, Mairesse J, Gelsi-Boyer V, Cheze S, Beyne-Rauzy O, Sébert M, Sapena R, Zerazhi H, Legros L, Guerci-Bresler A, Amé SN, Germing U, Santini V, Salvi F, Gioia D, Lunghi M, Dreyfus F, Fenaux P; Groupe Francophone des Myélodysplasies, Fondazione Italiana per le Sindromi Mielodisplastiche (FISMonlus), and Düsseldorf MDS Registry.
Br J Haematol. 2016 Dec;175(5):975-979. doi: 10.1111/bjh.13902. Epub 2016 Jan 15.
Refractory cytopenias with unilineage dysplasia: a retrospective analysis of refractory neutropenia and refractory thrombocytopenia.
Marinier DE, Mesa H, Rawal A, Gupta P.
Leuk Lymphoma. 2010 Oct;51(10):1923-6. doi: 10.3109/10428194.2010.506568.
[Myelodysplastic syndrome classification].
Ghariani I, Braham N, Hassine M, Kortas M.
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804.
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P, Loscertales J, Soto C, Ricard P, Novas CM, Martín-Clavero E, López-Rubio M, Garcia-Alonso L, Callejas M, Bermejo A, Benavente C, Ballesteros M, Cedena T, Calbacho M, Urbina R, Villarrubia J, Gil S, Bellón JM, Diez-Martin JL, Villegas A.
Ann Hematol. 2015 Apr;94(4):565-73. doi: 10.1007/s00277-014-2252-4. Epub 2014 Nov 13.
Refractory thrombocytopenia and neutropenia: a diagnostic challenge.
Gyan E, Dreyfus F, Fenaux P.
Mediterr J Hematol Infect Dis. 2015 Feb 18;7(1):e2015018. doi: 10.4084/MJHID.2015.018. eCollection 2015.
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.
Malcovati L, Cazzola M.
Br J Haematol. 2016 Sep;174(6):847-58. doi: 10.1111/bjh.14215. Epub 2016 Jul 8.
Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.
Yin CC, Medeiros LJ, Bueso-Ramos CE.
Int J Lab Hematol. 2010 Oct;32(5):461-76. doi: 10.1111/j.1751-553X.2010.01246.x. Epub 2010 Jul 7.
[Classification of myeloid leukemias].
Kuriyama K.
Nihon Rinsho. 2009 Oct;67(10):1853-62.
